Researcher.Life Logo

Journal of Antimicrobial Chemotherapy : Impact Factor & More

eISSN: 1460-2091pISSN: 0305-7453

Aims and Scope of Journal of Antimicrobial Chemotherapy

The Journal of Antimicrobial Chemotherapy is a peer-reviewed medical journal which covers antimicrobial chemotherapy, including laboratory aspects and clinical use of antimicrobial agents. It is published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy and was established in 1975. In January 2015 J. Peter Donnelly (Radboud University Nijmegen Medical Centre) became the eighth editor-in-chief replacing Alan P. Johnson (Health Protection Agency, London, United Kingdom). The journal has had two previous publishers. All content is available for free after 12 months while authors also have the option to have their articles published immediately as open access. Less

Key Metrics

CiteScore
9.4
H-Index
211
Impact Factor
5 - 10
Scite Index
0.86 5-Year SI
SJR
Q1Pharmacology
SNIP
1.65
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Antimicrobial Chemotherapy

Journal of Antimicrobial Chemotherapy Journal Specifications

Overview
Publisher OXFORD UNIV PRESS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1975
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Antimicrobial Chemotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Antimicrobial Chemotherapy

Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Antimicrobial activity of aztreonam-avibactam against KPC variant-producing Klebsiella pneumoniae with ceftazidime-avibactam resistance.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Antimicrobial activity of aztreonam-avibactam against KPC variant-producing Klebsiella pneumoniae with ceftazidime-avibactam resistance.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Phenotypic and genotypic characterization of HMB-3, a metallo-beta-lactamase from Pseudomonas asiatica.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy
Monte Carlo simulations identify suboptimal PK/PD target attainment with standard maribavir dosing.
  • 5 May 2026
  • The Journal of antimicrobial chemotherapy

FAQs on Journal of Antimicrobial Chemotherapy